OH
Organogenesis Holdings Inc
🇩🇪XFRA.2PQGermanyHealthcare
€1.27EURup +0.02 (+1.6%)OpenEnd of day6:06 PM
Price€1.27+0.02 (+1.6%)
Profile
- Healthcare
- Drug Manufacturers - Specialty & Generic
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US68621F1021
- CUSIP
- Not reported
Company
- Employees
- 854
- Headquarters
- Canton, United States
- Website
- https://organogenesis.com
- CEO
- Mr. Gary S. Gillheeney Sr.
Market
- Shares outstanding
- 126.9M
- Market cap
- €161.18M
Highlights
- Market cap
- €161.18M
- EPS LTM
- -$0.70
- P/E LTM
- -3.31
- Div yield
- 2.95%
Fundamentals (LTM)
- Revenue
- $456.54M+6.34%up year on year
- Net income
- -$90.23M-996.23%down year on year
- Gross margin
- 67.59%-9.36%down year on year
- Free cash flow
- $20.84M+144.94%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.